IQVIA HOLDINGS INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- IQVIA HOLDINGS INC. stock issued during period, shares, new issues for the quarter ending 2015-12-31 was 300.34K shares.
- IQVIA HOLDINGS INC. stock issued during period, shares, new issues for fiscal 2015 was 3.10M shares, a 50.06% increase from fiscal 2014.
- IQVIA HOLDINGS INC. stock issued during period, shares, new issues for fiscal 2014 was 2.07M shares, a 85.27% decline from fiscal 2013.
- IQVIA HOLDINGS INC. stock issued during period, shares, new issues for fiscal 2013 was 14.04M shares, a 4488.39% increase from fiscal 2012.
- IQVIA HOLDINGS INC. stock issued during period, shares, new issues for fiscal 2012 was 306.02K shares, a 227.92% increase from fiscal 2011.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2015-12-31 | 300.34K shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-11 | 3.10M shares 10-K · filed 2016-02-11 |
| 2014-12-31 | 2.07M shares 10-K · filed 2016-02-11 | |
| 2013-12-31 | 14.04M shares 10-K · filed 2016-02-11 | |
| 2012-12-31 | 306.02K shares 10-K · filed 2015-02-12 | |
| 2011-12-31 | 93.32K shares 10-K · filed 2014-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B |